<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001915'>Aplastic anemia</z:hpo> (AA) and hypoplastic <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (hMDS) are often difficult to distinguish </plain></SENT>
<SENT sid="1" pm="."><plain>However, an accurate diagnosis is important because the prognosis and treatment of these diseases may differ </plain></SENT>
<SENT sid="2" pm="."><plain>CD34+ hematopoietic progenitors are central to the pathogenesis of both disorders; they are the targets of the autoimmune attack in AA and <z:e sem="disease" ids="C0007621" disease_type="Neoplastic Process" abbrv="">neoplastic transformation</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of this study was to assess whether bone marrow CD34+ cell numbers could be used in differentiating between AA and hMDS </plain></SENT>
<SENT sid="4" pm="."><plain>The percentage of bone marrow CD34+ cells was <z:mpath ids='MPATH_458'>normal</z:mpath> or increased (mean -3.5+0.5%, range 1-7%) in 15 of 35 patients studied, and low (mean -0.13 +/- 0.02%, range 0.02-0.36%) in 20 of 35 patients </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients with a <z:mpath ids='MPATH_458'>normal</z:mpath> or increased percentage of CD34+ cells were ultimately diagnosed with hMDS based on the detection of clonal cytogenetic abnormalities or progression to <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts/<z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients with low marrow CD34+ cell numbers met standard clinical criteria for AA and have not demonstrated <z:e sem="disease" ids="C0007621" disease_type="Neoplastic Process" abbrv="">neoplastic transformation</z:e> with follow-up </plain></SENT>
<SENT sid="7" pm="."><plain>Quantification of marrow CD34+ cells may serve as an important tool for distinguishing between AA and hMDS </plain></SENT>
</text></document>